Help us beat the number one toddler cancer. Please donate today to support world class Australian research into developing better, safer treatments with the ultimate goal of finding a definitive cure for all children diagnosed with neuroblastoma. Read more
If you're unable to join us in Sydney on April 2 for Run2Cure, you can still get involved in your local area as part of the Run2Cure Local 2023 Appeal and fundraise for childhood cancer neuroblastoma. Read more
Support vital world class Australian neuroblastoma research, where the need is greatest to help find better, kinder and safer treatments. Each new research and each new breakthrough gives families of children with neuroblastoma - hope, hope for a cure and promise of a future. Read more
Take a look at the appeals we are currently raising funds for below. You can choose to donate or you can set up your own fundraising page.
Please give the gift of hope to children with neuroblastoma cancer this Christmas. By making donation today, you can help fund leading research into this devastating childhood cancer so we can change survival rates and ensure affected children live a long and healthy life. Read more
By making a EOFY tax-deductible donation today, you can help children like Hayley. Funding leading research into this devastating childhood cancer can change survival rates and ensure affected children live a long and healthy life. Read more
Meet Neuroblastoma Australia's Super Supporter - Natalie, who has been raising funds and awareness for neuroblastoma for over 8 years. Next up for Natalie, she will be fundraising by running the New York City Marathon on 6 November 2022 - 42.2km for her 2 Many 2 Young Appeal. Natalie will of course be running in her legendary 2-2 (tutu). Read more
Brighten a child's day - for as little as $59, you can gift a child with neuroblastoma a fun Activity Pack to keep them entertained and engaged whilst isolated indoors at home or in hospital. Read more
Venetoclax is a promising drug currently in trial for a number of cancers, including neuroblastoma BUT in combination with another agent we think it'll perform even better. Dr Jamie Fletcher from the Children's Cancer Institute needs funding to identify these combinations. Thank you for making this happen! Read more